Article
Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP.
Genes & development - 1 Feb 2000
Kung A L, Rebel V I, Bronson R T, Ch'ng L E, Sieff C A, Livingston D M, Yao T P
Abstract excerpt
Mice with monoallelic inactivation of the CBP gene develop highly penetrant, multilineage defects in hematopoietic differentiation and, with advancing age, an increased incidence of hematologic malignancies. The latter are characterized, at least in some cases, by loss of heterozygosity (LOH) at the CBP locus. No such pathology was observed in wild-type or p300 heterozygous null mice of the same age and genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
